Federal Register / Vol. 62, No. 152 / Thursday, August 7, 1997 / Notices 42587

Contact Person: Wilna Woods, Ph.D.,

Scientific Review Administrator, National

Cancer Institute, NIH, Executive Plaza North,

Room 622B, 6130 Executive Boulevard, MSC

7410, Bethesda, MD 20892–7410, Telephone:

301/496–7903.

Purpose/Agenda: To evaluate and review

responses to Request for Proposal.

This notice is being published less than 15

days prior to the meeting due to the urgent

need to meet timing limitations imposed by

the review and funding cycle.

The meeting will be closed in accordance

with the provisions set forth in secs.

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.

Proposals and the discussions could reveal

confidential trade secrets or commercial

property such as patentable material and

personal information concerning individuals

associated with the proposals, the disclosure

of which would constitute a clearly

unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance

Program Numbers: 93.393, Cancer Cause and

Prevention Research; 93.394, Cancer

Detection and Diagnosis Research; 93.395,

Cancer Treatment Research; 93.396, Cancer

Biology Research; 93.397, Cancer Centers

Support; 93.398, Cancer Research Manpower;

93.399, Cancer Control)

Dated: July 31, 1997.

LaVerne Y. Stringfield,

Committee Management Officer, National

Institute of Health.

[FR Doc. 97–20857 Filed 8–6–97; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

Notice of Closed Meeting of the

National Deafness and Other

Communication Disorders Advisory

Council

Pursuant to Pub. L. 92–463, notice is

hereby given of the meeting of the

National Deafness and Other

Communication Disorders Advisory

Council from 1–2 pm on September 11,

1997, in Building 31, Room 3C05,

National Institutes of Health, 9000

Rockville Pike, Bethesda MD 20892. The

meeting will be held as a telephone

conference call.

In accordance with the provisions set

forth in sections 552b(c)(4) and

552b(c)(6), Title 5, United States Code

and section 10(d) of Pub. L. 92–463, the

meeting will be closed to the public.

The meeting will include the review,

discussion, evaluation of individual

grant applications. The applications and

the discussions could reveal

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Further information concerning the

meeting may be obtained from Dr. Craig

A. Jordan, Executive Secretary, National

Deafness and Other Communication

Disorders Advisory Council National

Institute on Deafness and Other

Communication Disorders, National

Institutes of Health, Executive Plaza

South, Room 400C, 6120 Executive

Blvd., MSC7180, Bethesda, Maryland

20892–7180, (301) 496–8693. A

summary of the meeting and rosters of

the members may also be obtained from

his office.

(Catalog of Federal Domestic Assistance

Program No. 93.173 Biological Research

Related to Deafness and Communication

Disorders)

Dated: July 31, 1997.

LaVerne Y. Stringfield,

Committee Management Officer, National

Institutes of Health.

[FR Doc. 97–20858 Filed 8–6–97; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Heart, Lung, and Blood

Institute; Notice of Meeting

Pursuant to Pub. L. 92–463, notice is

hereby given of the meeting of the

following National Heart, Lung, and

Blood Institute Special Emphasis Panel.

The meeting will be open to the

public to provide concept review of

proposed contract or grant solicitations.

Individuals who plan to attend and

need special assistance, such as sign

language interpretation or other

reasonable accommodations, should

inform the Contact Person listed below

in advance of the meeting.

Name of Panel: Clinical Trials in Diabetes

and CVD.

Date: September 19, 1997.

Time: 8:00 a.m.

Place: NIH Main Campus, 31 Center Drive,

Building 31, 6th Floor, C Wing, Conference

Room 7.

Agenda: To consider the need for a clinical

trial to determine optimal intervention

strategies to prevent or reduce CVD in

diabetic patients.

Contact Persons:

Peter Savage, M.D., Deputy Director, DECA,

II Rockledge Center, 6701 Rockledge Drive,

MSC 7938, Room 8104, Bethesda,

Maryland 20892–7938, (301) 435–0422.

George Sopko, M.D., Medical Officer, DHVD,

II Rockledge Center, 6701 Rockledge Drive,

MSC 7940, Room 9176, Bethesda, MD

20892–7940, (301) 435–0515.

(Catalog of Federal Domestic Assistance

Programs Nos. 93.837, Heart and Vascular

Diseases Research; 93.838, Lung Diseases

Research; and 93.839, Blood Diseases and

Resources Research, National Institutes of

Health.)

Dated: July 31, 1997.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 97–20864 Filed 8–6–97; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Heart, Lung, and Blood

Institute; Notice of Meeting

Pursuant to Pub. L. 92–463, notice is

hereby given of the meeting of the

following National Heart, Lung, and

Blood Institute Special Emphasis Panel.

The meeting will be open to the

public to provide concept review of

proposed contract or grant solicitations.

Individuals who plan to attend and

need special assistance, such as sign

language interpretation or other

reasonable accommodations, should

inform the Contact Person listed below

in advance of the meeting.

Name of Panel: New Approaches to

Complex Biological Problems: Inflammation

and Risk Assessment.

Date: September 19, 1997.

Time: 8:00 a.m.

Place: Two Rockledge Center, 6701

Rockledge Drive, Room 7111, Bethesda,

Maryland 20892.

Agenda: To consider the approach and

need for additional research to improve

understanding of the pathogenesis of

inflammation in the lung and clinical risk

assessment related to it by use of non-linear

mathematical techniques.

Contact Person: Hannah H. Peavy, M.D.,

NHLBI/DLD Lung Biology and Disease

Program, Two Rockledge Center, Room

10110, 6701 Rockledge Drive, MSC 7952,

Bethesda, Maryland 20892, (301) 435–0222.

(Catalog of Federal Domestic Assistance

Programs Nos. 93.837, Heart and Vascular

Diseases Research; 93.838, Lung Diseases

Research; and 93.839, Blood Diseases and

Resources Research, National Institutes of

Health)

Dated: July 31, 1997.

LaVerne Y. Stringfield,

Committtee Management Officer, NIH.

[FR Doc. 97–20865 Filed 8–6–97; 8:45 am]

BILLING CODE 4140–01–M